Status
Enrollment closed
Condition
Chronic Coronary Heart Disease (CHD) blocked or narrowing arteries in the heart
Description
A Clinical Outcomes Study of Darapladib versus Placebo in Persons with CHD to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Purpose
The purpose of this study is to test a potential new drug called darapladib. We want to find out how well it works and test its safety. We want to find out what effects, good or bad, it has on persons with CHD
Phase
III
Key Inclusion Criteria
Chronic CHD documented
Key Exclusion Criteria
Planned coronary revascularization (PCI or bypass surgery (CABG)) or any other major surgical procedure.
ClinicalTrials.gov Identifier
NCT00799903
